Shareholder Alert: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amgen Inc. - AMGNNewsfile Corp • 05/28/22
Amgen (AMGN) Up 6.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 05/27/22
NEW DATA SHOWCASES HOW AMGEN IS ADVANCING ALL ANGLES OF CANCER CARE THROUGH INNOVATIVE ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2022PRNewsWire • 05/26/22
AMGEN AND LANCE BASS PARTNER TO ENCOURAGE PEOPLE TO DO A 'DOUBLE TAKE' TO RECOGNIZE THE EARLY SIGNS OF PSORIATIC ARTHRITISPRNewsWire • 05/12/22
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 05/04/22
Ongoing Investigation Alert: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 05/03/22
Why the 5 Highest-Yielding Nasdaq Stocks May Be the Best and Safest Value Buys Now24/7 Wall Street • 05/03/22
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the FirmPRNewsWire • 04/29/22
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the FirmBusiness Wire • 04/29/22